These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17607123)

  • 1. No association between TGFBR1*6A and lung cancer.
    You W; Liu Z; Zhao J; Zheng M; Zheng SY; Liu X; Zhang HT
    J Thorac Oncol; 2007 Jul; 2(7):657-9. PubMed ID: 17607123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
    Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
    Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
    Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL
    BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
    Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
    J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
    Colleran G; McInerney N; Rowan A; Barclay E; Jones AM; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E
    Breast Cancer Res Treat; 2010 Jan; 119(2):437-42. PubMed ID: 19390964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study.
    Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA
    BMC Cancer; 2010 Apr; 10():169. PubMed ID: 20429896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
    Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No major association between TGFBR1*6A and prostate cancer.
    Kaklamani V; Baddi L; Rosman D; Liu J; Ellis N; Oddoux C; Ostrer H; Chen Y; Ahsan H; Offit K; Pasche B
    BMC Genet; 2004 Sep; 5():28. PubMed ID: 15385056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
    JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age.
    Dutt SS; Chen N; Darbary HK; Swede H; Petrelli NJ; Stoler DL; Anderson GR
    Mutat Res; 2008 Oct; 645(1-2):27-32. PubMed ID: 18778720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of transforming growth factor β receptor I 6A/9A gene polymorphism and breast cancer risk: the picture remains murky.
    Ou C; Li H; Liu JH; Drummen GP; Zhu B; Huang LS; Huang Y; Li LQ
    Biomarkers; 2015; 20(6-7):487-94. PubMed ID: 26616150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia?
    Daley D; Morgan W; Lewis S; Willis J; Elston RC; Markowitz SD; Wiesner GL
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):892-4. PubMed ID: 17507611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis.
    Zhang X; Wu L; Sheng Y; Zhou W; Huang Z; Qu J; Gao G; Cai D; Zhang M
    Mol Biol Rep; 2012 Mar; 39(3):2567-74. PubMed ID: 21858550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE and TGFBR1 genes interact in influencing the susceptibility to abdominal aortic aneurysm.
    Lucarini L; Sticchi E; Sofi F; Pratesi G; Pratesi C; Pulli R; Gensini GF; Abbate R; Pepe G; Fatini C
    Atherosclerosis; 2009 Jan; 202(1):205-10. PubMed ID: 18550062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.
    Skoglund Lundin J; Vandrovcova J; Song B; Zhou X; Zelada-Hedman M; Werelius B; Houlston RS; Lindblom A
    Br J Cancer; 2009 May; 100(10):1674-9. PubMed ID: 19401691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.
    Liao RY; Mao C; Qiu LX; Ding H; Chen Q; Pan HF
    Mol Biol Rep; 2010 Oct; 37(7):3227-32. PubMed ID: 19882361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFBR1 polymorphism and risk of breast cancer in Iranian women.
    Kamali E; Hemmati S; Safari F; Tavassoli M
    Int J Biol Markers; 2015 Nov; 30(4):e414-7. PubMed ID: 26165686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TbetaR-I(6A) is a candidate tumor susceptibility allele.
    Pasche B; Kolachana P; Nafa K; Satagopan J; Chen YG; Lo RS; Brener D; Yang D; Kirstein L; Oddoux C; Ostrer H; Vineis P; Varesco L; Jhanwar S; Luzzatto L; Massagué J; Offit K
    Cancer Res; 1999 Nov; 59(22):5678-82. PubMed ID: 10582683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transforming growth factor-β receptor genes and the risk of intracranial aneurysms.
    Ruigrok YM; Baas AF; Medic J; Wijmenga C; Rinkel GJ
    Int J Stroke; 2012 Dec; 7(8):645-8. PubMed ID: 21978186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.